207 related articles for article (PubMed ID: 15708636)
1. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
[TBL] [Abstract][Full Text] [Related]
3. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
[TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside inhibitors of herpesviruses.
Wathen MW
Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
[TBL] [Abstract][Full Text] [Related]
6. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
Reusser P
Schweiz Med Wochenschr; 1994 Jan; 124(4):152-8. PubMed ID: 8128197
[TBL] [Abstract][Full Text] [Related]
7. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
8. [Drugs active against herpesviruses].
Fillet AM
Rev Prat; 1997 Mar; 47(6):623-30. PubMed ID: 9183936
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate.
Milbradt J; Auerochs S; Korn K; Marschall M
J Clin Virol; 2009 Sep; 46(1):24-8. PubMed ID: 19501020
[TBL] [Abstract][Full Text] [Related]
12. Herpesviridae and novel inhibitors.
Siakallis G; Spandidos DA; Sourvinos G
Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
14. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine.
Smith KO; Galloway KS; Hodges SL; Ogilvie KK; Radatus BK; Kalter SS; Heberling RL
Am J Vet Res; 1983 Jun; 44(6):1032-5. PubMed ID: 6307092
[TBL] [Abstract][Full Text] [Related]
19. Testing the susceptibility of human herpesviruses to antivirals.
Agut H; Boutolleau D; Deback C; Bonnafous P; Gautheret-Dejean A
Future Microbiol; 2009 Nov; 4(9):1111-23. PubMed ID: 19895215
[TBL] [Abstract][Full Text] [Related]
20. Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
Nieman JA; Nair SK; Heasley SE; Schultz BL; Zerth HM; Nugent RA; Chen K; Stephanski KJ; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Wathen MW
Bioorg Med Chem Lett; 2010 May; 20(10):3039-42. PubMed ID: 20403696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
